FDA Adverse Event Injury Summary report: N

MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S3 RM

MDR report key: 10755026 · Received October 29, 2020

Report

Report Number
3005180920-2020-00750
Event Type
Injury
Date Received
October 29, 2020
Date of Event
September 29, 2020
Report Date
October 29, 2020
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
HSX
UDI-DI
07630030895586
PMA / PMN Number
K162084
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

BATCH REVIEW PERFORMED ON (B)(6) 2020. LOT 189249: 48 ITEMS MANUFACTURED AND RELEASED ON 13-MAR-2019. EXPIRATION DATE: 02-MAR-2024. NO ANOMALIES FOUND RELATED TO THE PROBLEM TO DATE, 46 ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT. OTHER DEVICE INVOLVED IN THE EVENT. MOTO PARTIAL KNEE 02.18.TF4.RM TIBIAL TRAY FIX CEMENTED S4 RM LOT. 189256 (K162084). BATCH REVIEW PERFORMED ON (B)(6) 2020. LOT 189256: 50 ITEMS MANUFACTURED AND RELEASED ON 27-FEB-2019. EXPIRATION DATE: 17-FEB-2024. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 41 ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT. MOTO PARTIAL KNEE 02.18.IF4.09.RM TIBIAL INSERT FIX S4 RM - 9MM LOT. 189282 (K162084) BATCH REVIEW PERFORMED ON (B)(6) 2020. LOT 189282: 35 ITEMS MANUFACTURED AND RELEASED ON 09-APR-2019. EXPIRATION DATE: 26-MAR-2024. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, 26 ITEMS OF THE SAME LOT HAVE BEEN ALREADY SOLD WITHOUT ANY OTHER SIMILAR REPORTED EVENT.

Description of Event or Problem · 1

THE PATIENT CAME IN REPORTING PAIN 11 MONTHS AFTER THE PRIMARY SURGERY. THE SURGEON REVISED ALL MOTO IMPLANTS TO SPHERE IMPLANTS. THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1224326 MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S3 RM ANATOMICAL FEMORAL COMPONENT HSX MEDACTA INTERNATIONAL SA 02.18.003RM 189249 07630030895586

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention